Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The main objective of the trial is to determine whether the current topical formulation of GTX 2/3 reduces the wrinkling of the skin (crow\'s feet) after a single application Other evaluation criteria include: safety assessment and local tolerance, depth of facial wrinkles (video microscopy imaging).
Epistemonikos ID: e5150c290d1e73342627dc94ccf7e53c034f7ede
First added on: May 05, 2024